Jaws Mustang Acquisition Corp

Trust per share is approximately $11.57, well above the original $10.00, but the trust has been nearly exhausted by redemptions. The remaining public float is miniscule (89,480 Class A shares subject to redemption). The sponsor owns 25,500,000 Class A shares (99.65% of Class A) and 300,000 Class B shares, giving it near-total control (99.37% voting power). The SPAC has a stated deadline of December 4, 2026 to find a deal, but with minimal cash, a going-concern warning, and no identified replacement for the abandoned hotel deal, the likelihood of completing a business combination is very low. The delisting to OTC Pink further reduces liquidity and marketability. The fee waivers from all three underwriters (BofA, Goldman, Credit Suisse) already eliminated deferred underwriting fees, and the $1.48 million sponsor advance indicates continued sponsor support but also deepening dependence on related-party credit.

The registrant’s regulatory submission permanently restructures timeline governance by transferring future extension authority from public shareholder votes to Board action triggered exclusively by sponsor direction. The documented trust depletion removes more than fourteen million dollars from the captive capital pool, leaving roughly one million dollars to fund ongoing search activities and cover potential wind-up costs, as the amended Article 49.7 authorizes withholding up to US$100,000 of trust interest for dissolution expenses. For investors tracking liquidity constraints and exit viability, the filing anchors the residual trust value at approximately $1,027,603 and reiterates the registered security structure under the Exchange Act, listing each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50. The overwhelming approval margin signals sponsor-shareholder alignment on the revised timeframe, though the contracted trust balance materially narrows the universe of feasible acquisition targets and alters the economic floor for remaining public holders.

The filing materially resets the redemption calendar for JWSMF, moving the immediate liquidation horizon from mid-December 2024 to early January 2025 while locking in a mechanism that lets the Sponsor and Board unilaterally stretch the search period month-by-month through December 4, 2026 without further public shareholder input. The disclosed redemptions drain the trust account down to approximately $1,027,603, meaning any future business combination financing or forced liquidation will rest on a substantially depleted cash pool. By amending Article 49.7 to allow monthly extensions upon Sponsor request, public investors forfeit periodic renewal votes, concentrating timing risk in management’s hands until the December 2026 sunset. The revised provisions also codify that, upon eventual dissolution, shareholders will receive the prorated Trust balance after deductions for taxes and up to US$100,000 designated for dissolution expenses, directly impacting residual recovery projections.

The filing provides critical updates for investors tracking the SPAC's rapidly approaching redemption deadline of December 4, 2024 (with potential to extend to February 4, 2025 if all eleven monthly extensions are exercised). Trust value per redeemable share is $11.39, above the IPO price, but the company has minimal operating cash and a negative working capital position. The delisting from NYSE American to OTC Pink may reduce liquidity and marketability. The LOI with Starwood Capital Entities (hotel portfolio) remains unsigned, and no definitive agreement has been reached. Sponsor conduct includes conversion of founder shares, continued related-party loans, and assignment of the 2024 Note to Starwood. These factors are material to assessing the likelihood of completing a business combination and the potential return of trust proceeds to public shareholders.

This extension is critical for the SPAC to avoid liquidation and continue searching for a target. The high sponsor ownership ensures approval. Shareholders have redemption rights at ~$11.45 per share, which is above the recent market price of $11.30, creating an arbitrage opportunity. The delisting to OTC Pink reduces liquidity and could impact trading. The trust is now in cash earning minimal interest, so no further growth in trust value. The filing provides the specific mechanics for redemption and the timeline for the meeting on November 26, 2024.

The suspension of the hospitality target eliminates the active merger pathway, leaving the company in a pure search phase while preserving the existing trust account and shareholder equity structure. The $400,000 note establishes a direct financial obligation that explicitly waives claims against the trust account, meaning the payee recovers only from external corporate assets if a combination fails. The migration to OTC Markets maintains periodic reporting compliance under the Exchange Act without triggering mandatory redemptions or warrant conversions. As outlined in the company overview, Chairman Barry S. Sternlicht and Chief Executive Officer Andrew Klaber continue to oversee operations while seeking replacement hotel interests outside the Initial Portfolio.

This is a critical extension vote. Without approval, the SPAC will liquidate by December 4, 2024. The trust balance is approximately $15.4 million after prior redemptions, and the public float is small. The delisting from NYSE American reduces liquidity and marketability. The extension would give the sponsor up to two more years to find a deal, but the company faces significant risks including potential further redemptions and the challenge of completing a business combination with a depleted trust. The outcome is highly likely to pass due to insider control, but the trust per-share value is well above the current trading price, creating an arbitrage opportunity for redeeming shareholders.

This filing confirms the Company has missed its business combination window, triggering mandatory delisting and signaling that shareholder redemption and liquidation are now the operational path forward rather than a merger closing. The Exchange explicitly ties the delisting to the 36-month completion requirement, which indicates that the original financing timeline has concluded without a target. The document specifies that each whole Redeemable Warrant carries an exercise price of $11.50, though those instruments will cease trading on a national exchange after November 12, 2024. The text contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Trust value and final distribution mechanics are governed by the certificate of incorporation and trustee instructions rather than the Exchange, so investors tracking the redemption deadline and per-share payout should await corporate communications specifying the exact dollar amount held in trust and the final distribution schedule.

This filing gives the current redemption math and deadline for a searching SPAC: public redemption value is about $11.23 per trust-account share, and if no deal closes by Sept. 4, 2024 the company says it will liquidate unless further monthly extensions are exercised through Feb. 4, 2025. The disclosed Starwood hotel deal remains non-binding, so the redemption calendar is the key investor tracking point. Sponsor behavior is also relevant: the sponsor converted founder shares, is funding working capital through related-party notes, and assigned one note to the prospective deal counterparty's management arm, signaling continued pursuit of the Starwood transaction while the company burns through outside-trust cash ($30,219 at period end and a $4,614,700 working capital deficit).

The filing confirms the SPAC is actively pursuing a hotel deal but is burning cash, relying on sponsor loans to fund operations. The trust value per share is $11.08, and with only 1.4 million public shares left, redemptions are likely. The company faces a tight deadline (June 4, 2024) before potential liquidation, and its auditor has raised substantial doubt about its ability to continue as a going concern. The sponsor's continued financing and the progress of the Starwood LOI are critical for the stock's future.

This filing reveals the SPAC's drastically reduced trust, the specific hotel portfolio target under LOI, the tight deadline of May 4, 2024, and the sponsor's financial support through loans and share conversion. It signals high risk of liquidation if the business combination is not completed imminently, and provides concrete details for investors evaluating redemption timing and deal prospects.

Although this is a routine compliance procedure that leaves the corporate merger timeline, current trust mechanics, and shareholder redemption rights entirely intact, late 10-K notifications in pre-combination SPACs frequently surface during periods of audit complexity, board friction, or deferred target diligence. Per the company’s representation in the filing, Andrew Klaber confirms that all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months were filed timely, and he states there will be no significant change in results of operations from the corresponding period for the last fiscal year. Beyond the executive attribution, the listed contact details for Andrew Klaber (305 695-5500), and the reference to the transition window ending prior to the fifteenth calendar day, the document contains no substantive operational disclosures, no target pipeline updates, no revenue or market-size assertions, no technology or partnership claims, and no litigation or personnel developments. Its materiality stems from tracking sponsor execution pacing and compliance reliability rather than transaction economics.

The submission identifies the specific target assets (Starwood-affiliated hospitality brands) and maps the near-term regulatory sequence (definitive agreement → Form S-4 → preliminary proxy), establishing the timeline shareholders should track before redemption windows open and pro forma valuations are calculated. The attached promissory note functionally de-risks the public trust account ($11.99 per share) by contractually prohibiting sponsor recourse to trust monies in a liquidation scenario, while simultaneously providing up to $500,000 of bridge financing that converts to equity or is extinguished only upon successful combination. Because the note's default and repayment covenants expressly carve out the trust estate, the filing confirms that operational funding does not encroach on shareholder redemption rights or trigger extension voting requirements. With no amendments to the 2026-12-04 deadline, no modifications to the $11.50 warrant exercise price, and no changes to the $0.0001 par value structure, investor attention shifts entirely to the execution of the definitive agreement and the forthcoming proxy proxy materials that will detail dilution, lock-up arrangements, and cash sources.

The disclosed credit facility injects up to $500,000 in off-trust working capital, preserving the full Trust Account for shareholders and eliminating near-term liquidity pressure prior to the extension-free deadline. The contractual trust waiver reinforces sponsor alignment, ensuring public investors face no subordinate liens or reimbursement demands during a default or termination scenario. By naming the specific hotel assets and detailing the procedural next steps toward a prospectus, the filing moves the candidate merger from vague search parameters to a documented pipeline stage, allowing investors to track asset specificity and regulatory milestones without triggering premature voting or redemption calculations.

Substantive claims regarding portfolio assets, revenue metrics, strategy, partnerships, and personnel: According to the press release attached to the filing, the prospective target ‘Initial Portfolio’ comprises ten hospitality properties: the 1 Hotel Brooklyn Bridge (195 guest rooms and suites), the 1 Hotel Central Park (234 guest rooms and suites), and eight De Vere UK estates spanning central and northern England totaling 1,871 guest rooms and suites. The Starwood Capital Entities’ management attributes an estimated property-level Net Operating Income (“NOI”) of $52 million to the portfolio for the year ended December 31, 2023, and projects $62 million in NOI for the year ending December 31, 2024. Management states the two New York hotels will continue operating under external management by SH Group Hotels & Residences U.S., LLC, while the De Vere portfolio remains under an internal operational team. Regarding future strategy, the parties expect the combined company to ‘seek to acquire additional hotel properties, including 1 Hotel properties.’ Barry Sternlicht, who founded 1 Hotels in 2015 and serves as Jaws Chairman, described the brand as a ‘mission-driven luxury lifestyle platform’ centered on environmental sustainability. Personnel disclosures confirm Jaws is led by Chairman Barry S. Sternlicht and CEO Andrew Klaber, with media relations directed through Tom Johnson and Emma Prenn-Vasilakis of H/Advisors Abernathy. The filing consistently cautions that these forward-looking income estimates may materially deviate from GAAP-compliant metrics once audited and included in the definitive proxy statement.

This announcement materially advances deal progress from a blank-check search status to a defined target pipeline, triggering anticipated regulatory disclosures including a future Form S-4 registration statement and preliminary proxy statement that will finalize shareholder voting timelines, offer prices, and redemption procedures. According to the Starwood Capital Entities presentation attached to the filing, the proposed Initial Portfolio consists of ten properties: 1 Hotel Brooklyn Bridge comprising 195 guest rooms and suites, 1 Hotel Central Park comprising 234 guest rooms and suites, and the De Vere Portfolio spanning central London, outer London, Southern England, and Northern England comprising 1,871 guest rooms and suites. The Starwood Capital Entities management projects the Initial Portfolio earned $52 million of Net Operating Income at the property level for the year ended December 31, 2023, and forecasts the portfolio will earn NOI at the property level of $62 million for the year ending December 31, 2024. These income estimates and all subsequent projections are expressly characterized as forward-looking statements based on assumptions subject to significant uncertainties, not guaranteed results. Strategy-wise, the Starwood Capital Entities state the combined public company will continue to be managed externally for the 1 Hotels properties by SH Group Hotels & Residences U.S., LLC, retain the De Vere Portfolio under its internal operational team, and pursue ongoing acquisitions of additional hotel properties including 1 Hotel properties. Santander US Capital Markets LLC is engaged as equity capital markets advisor and financial advisor to Jaws. Supporting corporate profile figures disclosed by Starwood Capital Group indicate the firm maintains 16 offices in seven countries, employs 5,000+ individuals, has raised over $75 billion of capital since founding in 1991, currently oversees ~$115 billion of assets under management, and manages Starwood Property Trust (NYSE: STWD), which has deployed over $95 billion of capital since inception and holds a portfolio of over $27 billion across debt and equity investments. None of these corporate scale metrics or operational targets constitute binding transaction economics or audited financials until a definitive agreement and proxy are filed.

The twelve-month extension framework replaces individual shareholder approval cycles with board-managed deadlines tied to Sponsor funding, fundamentally altering the SPAC’s cash-burn runway and redemption horizon. The roughly $7.66 million redemption outflow concentrates remaining trust liquidity, making subsequent extension deposits and working capital availability critical to avoiding forced dissolution or listing delisting. The Sponsor’s full conversion of founder shares eliminates traditional founder lockup mechanisms, aligning insider economic exposure with public shareholders while the explicit trust waiver prevents further capital dilution from promoter positions. Updated governance provisions remove class-specific voting hurdles for extensions past February 4, 2025 and codify the 20 percent dilution baseline, directly shaping target negotiation leverage, lock-up structuring, and exit timing expectations for remaining investors.

The extension shifts the governance mechanism for prolonging the SPAC lifecycle from recurring shareholder votes to Board and Sponsor discretion, providing operational continuity but introducing a monthly cash infusion requirement for the Sponsor. The redemption volume directly diminishes the trust capital available to finance a future acquisition, requiring sponsors to weigh the remaining ~$15.4 million balance against target valuation and transaction costs. The complete conversion of Class B Founder Shares into publicly-tradable Class A shares structurally aligns promoter and public equity classes, eliminating the traditional post-merger dilution gap; however, the sponsor's formal waiver of trust distribution rights for the newly converted shares ensures that existing public shareholder proceeds remain undiluted by the increased public float.

This filing materially alters the timeline and environment for shareholders tracking redemptions and potential liquidations. By seeking an appeal to gain additional time, management signals that while the initial expiration window passed, they are pursuing a procedural extension rather than immediately winding down. The continued trading status during the appeal preserves liquidity but introduces uncertainty regarding whether the requested extension will be granted by NYSE American or if forced termination and trust distribution loom. No new trust account balances, per-share redemption values, revised deadline extensions, or sponsor financing commitments are disclosed in this submission.

According to the registrant's disclosure, this adjournment and withdrawal deadline extension materially shifts the near-term redemption mechanics, granting holders roughly fourteen additional days to reverse redemption elections before the final extension vote. The company's board indicates that retaining these shares in the trust preserves higher per-share cash balances for subsequent business combinations or liquidation, directly delaying trust depletion. The 96.78% quorum attainment and lopsided vote margins demonstrate that participating holders and likely sponsor-aligned interests prefer continued search operations over immediate dissolution, signaling disciplined timeline management despite the absence of a finalized target. Securities mechanics referenced in the filing confirm Class A ordinary shares carry a $0.0001 par value, and whole warrants remain exercisable for one share at $11.50. No acquisition targets, valuation metrics, customer contracts, revenue data, market size estimates, technology roadmaps, partnership announcements, or litigation matters were disclosed by management or the board. All procedural updates and voting tallies were reported by the registrant and certified by Chief Executive Officer Andrew Klaber.

This filing directly impacts cash flow mechanics by postponing the redemption withdrawal cutoff, thereby delaying any immediate trust account drain before the rescheduled vote. The reported 96.78% quorum and near-unanimous approval margin indicate active sponsor management and aligned shareholder sentiment toward securing additional time to locate a business combination target, rather than liquidating and distributing funds. While no new revenue figures, customer contracts, or strategic partnership data appear in this specific 8-K, the registrant points investors to its Definitive Proxy Statement filed January 11, 2024, for comprehensive extension terms. Capital structure disclosures confirm warrant exercisability at $11.50 per share, with equity trading on NYSE American under JWSM and JWSM WS. Executed by Chief Executive Officer Andrew Klaber.

This filing materially adjusts the redemption calendar and trust liquidity framework by finalizing 1,023,321 redemptions while opening a short-lived withdrawal window that could shift the January 25 voting outcome. The board-only extension mechanism removes the immediate risk of liquidation but concentrates timeline control in management rather than public shareholders. The Sponsor's pledge to convert founder shares and waive trust proceeds reduces future dilution pressure and aligns economic incentives with public holders, but it also permanently transfers 25,500,000 restricted founder shares into the public float without adding trust capital, which impacts per-share valuations and ongoing voting power distributions.

The reported 1,023,321 redemptions permanently reduce the public float and decrease the aggregate trust proceeds available to fund a business combination or support a continued operation, though the sponsor’s planned conversion of 25,500,000 founder shares will offset dilution without drawing down remaining trust capital. The sponsor’s explicit waiver of trust claims for converted shares, as stated by Mustang Sponsor LLC, preserves residual trust equity for surviving public holders or a future acquisition target. Extending the operational mandate to early 2025 shifts the timeline for shareholder exit windows, liquidity events, and potential deal negotiations. The filing also confirms enduring instrument terms: whole warrants remain exercisable at $11.50 per warrant, and both Class A and Class B ordinary shares carry a par value of $0.0001. Under a letter agreement dated February 1, 2021, shares received via the announced conversion will inherit the original lock-up, voting, and transfer restrictions. Chief Executive Officer Andrew Klaber executed the report on January 24, 2024, formally certifying these procedural mechanics and structural waivers.

Shareholders must decide whether to approve the extension or face liquidation. Redemption deadline is January 23, 2024 at 5:00 p.m. ET. The trust value is ~$10.94 per share vs. market price of $10.90. Sponsor and insiders control 93.2% of shares, making approval likely. The founder share amendment could affect dilution and voting control. If extension fails, the SPAC will liquidate.

What changed: Form 10-Q quarterly report filed by Jaws Mustang Acquisition Corp (a SPAC) for the quarter ended March 31, 2025. No new business combination announcement. No new extension deposits. Net loss widened slightly to -$507,977 from -$7,159,904 (largely due to a smaller change in warrant fair value). Cash outside trust fell to $153,305 from $319,207. Working capital deficit is $2.68 million. Trust per-share redemption value crept up to ~$11.65 from ~$11.57 due to interest. The public warrants were transferred from Level 1 to Level 2 fair-value classification (limited trading volume). Management again expresses substantial doubt about going concern; the termination date has been extended monthly to June 4, 2025, with a final possible deadline of December 4, 2026 if all 23 monthly extensions are exercised. Why it matters: This filing shows a SPAC running out of time and cash. With only $153,000 cash outside trust, a $2.68 million working capital deficit, and no announced deal, the company is fully dependent on the sponsor/Starwood to keep extending. The trust, however, holds $1.04 million for the remaining 89,480 public shares, providing a $11.65 floor. Any redemption-timing catalyst (a deal announcement or an extension vote) will be highly consequential. The Level 2 reclassification for public warrants hints at deteriorating market liquidity.

What changed: 10-K (Annual Report for fiscal year ended December 31, 2024). The trust account balance was nearly drained to $1,035,353 (vs. $23,004,146 at year-end 2023) after a third extension vote in November 2024 triggered redemptions of 1,315,813 shares at ~$11.48 for ~$15.1 million. The sponsor converted 25,500,000 Class B shares into Class A shares in February 2024, leaving only 375,000 Class B shares outstanding. The SPAC delisted from the NYSE American in November 2024 and now trades over-the-counter. The previously announced LOI with Starwood Capital hotel entities was suspended after the 1 Hotel Central Park was sold to Host Hotels & Resorts. The Termination Date was extended from December 4, 2024, and can now be extended monthly by the board up to twenty-three times, until December 4, 2026, with each extension requiring a $25,000 deposit. Net income was $1,682,254 (vs. $5,321,663 in 2023), largely due to a $2,109,554 forgiveness of previously recorded liabilities. Cash outside trust was $319,207; the company has a working capital deficit of $2,538,032 and has obtained $1,485,000 in advances from the sponsor and $1,400,000 in promissory notes from related parties. Management has identified substantial doubt about the company's ability to continue as a going concern. Why it matters: Trust per share is approximately $11.57, well above the original $10.00, but the trust has been nearly exhausted by redemptions. The remaining public float is miniscule (89,480 Class A shares subject to redemption). The sponsor owns 25,500,000 Class A shares (99.65% of Class A) and 300,000 Class B shares, giving it near-total control (99.37% voting power). The SPAC has a stated deadline of December 4, 2026 to find a deal, but with minimal cash, a going-concern warning, and no identified replacement for the abandoned hotel deal, the likelihood of completing a business combination is very low. The delisting to OTC Pink further reduces liquidity and marketability. The fee waivers from all three underwriters (BofA, Goldman, Credit Suisse) already eliminated deferred underwriting fees, and the $1.48 million sponsor advance indicates continued sponsor support but also deepening dependence on related-party credit.

What changed: A Form 8-K Current Report filed by Jaws Mustang Acquisition Corp on November 29, 2024, documenting the proceedings and outcomes of an extraordinary general meeting of shareholders held on November 26, 2024. The report discloses the approval of a special resolution amending the Company’s Cayman Islands memorandum and articles of association to extend the business combination deadline, alongside formal voting tallies and post-meeting redemption activity. Per the Company’s filing, the termination date for completing a business combination was formally extended from December 4, 2024, to January 4, 2025. The submitted Charter Amendment creates a new extension mechanism permitting the Board to lengthen the deadline on a monthly basis for up to twenty-three additional cycles, contingent only on a written request from Mustang Sponsor LLC and five days’ advance notice, thereby establishing a maximum possible expiration of December 4, 2026. The filing reports that 1,405,293 Class A ordinary shares were properly tendered for redemption at approximately $11.48 per share, generating aggregate redemption proceeds of approximately $15,111,008. Following those payouts, the Company confirms the Trust Account balance is approximately $1,027,603. Shareholder voting resulted in 26,380,004 votes for the amendment, 6,512 against, and 500 abstentions, with a verified quorum of 26,387,016 ordinary shares presented. Why it matters: The registrant’s regulatory submission permanently restructures timeline governance by transferring future extension authority from public shareholder votes to Board action triggered exclusively by sponsor direction. The documented trust depletion removes more than fourteen million dollars from the captive capital pool, leaving roughly one million dollars to fund ongoing search activities and cover potential wind-up costs, as the amended Article 49.7 authorizes withholding up to US$100,000 of trust interest for dissolution expenses. For investors tracking liquidity constraints and exit viability, the filing anchors the residual trust value at approximately $1,027,603 and reiterates the registered security structure under the Exchange Act, listing each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50. The overwhelming approval margin signals sponsor-shareholder alignment on the revised timeframe, though the contracted trust balance materially narrows the universe of feasible acquisition targets and alters the economic floor for remaining public holders.

What changed: A DEFA14A supplement accompanying a Form 8-K that reports the results of an extraordinary general meeting of shareholders held on November 26, 2024, documenting shareholder approval of a special resolution to amend the Company’s governing documents to extend the business combination termination date, alongside the disclosure of share redemptions triggered by that same meeting. Per the filed 8-K and attached Charter Amendment (Exhibit 3.1), the Company reports that the initial termination date has been extended from December 4, 2024, to January 4, 2025. The amended Article 49.7, as drafted in the submitted exhibit, permits the Company to extend the termination date on a monthly basis for up to twenty-three additional times without a further shareholder vote, contingent upon a Board resolution requested in writing by Mustang Sponsor LLC and delivered five days before each applicable termination date, pushing the ultimate outside date to December 4, 2026 (seventy months from IPO closing). The filing discloses that 1,405,293 Class A Ordinary Shares were properly redeemed at approximately $11.48 per share, yielding an aggregate redemption amount of approximately $15,111,008. Following those payouts, the filing states the Trust Account balance is approximately $1,027,603. Voting tallies reported in the 8-K show 26,380,004 shares voted in favor, 6,512 against, and 500 abstained, representing approximately 96.73% of outstanding voting power. Why it matters: The filing materially resets the redemption calendar for JWSMF, moving the immediate liquidation horizon from mid-December 2024 to early January 2025 while locking in a mechanism that lets the Sponsor and Board unilaterally stretch the search period month-by-month through December 4, 2026 without further public shareholder input. The disclosed redemptions drain the trust account down to approximately $1,027,603, meaning any future business combination financing or forced liquidation will rest on a substantially depleted cash pool. By amending Article 49.7 to allow monthly extensions upon Sponsor request, public investors forfeit periodic renewal votes, concentrating timing risk in management’s hands until the December 2026 sunset. The revised provisions also codify that, upon eventual dissolution, shareholders will receive the prorated Trust balance after deductions for taxes and up to US$100,000 designated for dissolution expenses, directly impacting residual recovery projections.

What changed: Form 10-Q (Quarterly Report) for the quarterly period ended September 30, 2024, filed by Jaws Mustang Acquisition Corporation, a blank-check company searching for a business combination. Trust account cash decreased from $23.0M at year-end 2023 to $16.0M at September 30, 2024, reflecting redemptions of 698,321 shares ($7.66M) in February 2024. Redemption value per share stood at $11.39. The company extended its combination deadline nine times to December 4, 2024, using $225,000 in extension funds from sponsor/Starwood notes. Subsequent to quarter end, an additional $50,000 was deposited for the eighth and ninth extensions (to November and December 2024), and a new $400,000 promissory note was issued to Starwood on October 31, 2024. The NYSE American delisted the company's securities effective November 1, 2024; trading moved to OTC Pink. The non-binding LOI with Starwood Capital Entities (announced March 8, 2024) remains without a definitive merger agreement. Working capital deficit widened to $4.75M; cash on hand fell to $34,688. Management reiterated substantial doubt about going concern if no deal by December 4, 2024. Why it matters: The filing provides critical updates for investors tracking the SPAC's rapidly approaching redemption deadline of December 4, 2024 (with potential to extend to February 4, 2025 if all eleven monthly extensions are exercised). Trust value per redeemable share is $11.39, above the IPO price, but the company has minimal operating cash and a negative working capital position. The delisting from NYSE American to OTC Pink may reduce liquidity and marketability. The LOI with Starwood Capital Entities (hotel portfolio) remains unsigned, and no definitive agreement has been reached. Sponsor conduct includes conversion of founder shares, continued related-party loans, and assignment of the 2024 Note to Starwood. These factors are material to assessing the likelihood of completing a business combination and the potential return of trust proceeds to public shareholders.

What changed: First, this document is a Schedule 13G/A amendment filed pursuant to Section 13(d) of the Securities Exchange Act of 1934. Then, regarding redemption deadlines, trust value, extensions, deal progress, and sponsor conduct, the filing contains no information bearing on these mechanics. Then, regarding other substance, the document contains no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. The only disclosed figures, attributed to Fir Tree Capital Management LP and certified by its General Counsel Brian Meyer, show that as of the September 30, 2024 event date, the reporting person owns 0 aggregate shares, holds 0 sole voting power, 0 shared voting power, 0 sole dispositive power, and 0 shared dispositive power, representing 0% of the class, and checks the Item 5 box to report it has ceased to be the beneficial owner of more than five percent of the class. Fir Tree Capital Management LP updated its Schedule 13G filing to reflect a full reduction of its beneficial ownership position in Jaws Mustang Acquisition Corp to zero shares as of September 30, 2024. The filing moves the reporting entity from a greater-than-five-percent threshold down to zero voting and dispositive power across all categories, triggering the Item 5 notification that the reporting person has ceased to exceed the five percent ownership mark. All securities reported as held were certified by General Counsel Brian Meyer to have been acquired and maintained in the ordinary course of business, not for the purpose of influencing control or participating in a transaction to change it. Why it matters: For investors tracking SPAC execution mechanics, the filing confirms that Fir Tree Capital Management LP no longer holds a reportable equity stake in the units, eliminating any residual voting influence, block trade risk, or coordinated action concerns tied to this specific institutional adviser. The drop to zero ownership occurs without commentary on the SPAC’s target search, trust preservation, extension timeline, or redemption pressure, reinforcing that this is a standard institutional portfolio adjustment. Investors can treat this as a clean exit for this holder, with no mechanical impact on the pending business combination window or shareholder liquidity events.

What changed: Schedule 13G/A (Amendment No. 1) filed under the Securities Exchange Act of 1934 to report a reduction in beneficial ownership of Jaws Mustang Acquisition Corporation Class A ordinary shares below the five-percent disclosure threshold. Cowen and Company, LLC amends its prior reporting to state that as of September 30, 2024, it beneficially owns 198,828 Class A ordinary shares, representing 0.7% of the outstanding class, with sole voting power and sole dispositive power over those shares. The filing checks the box indicating the reporting person has ceased to hold more than 5% of the class. John Holmes, Chief Operating Officer of Cowen and Company, LLC signs the certification on November 12, 2024, asserting the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. Why it matters: This amendment does not modify the SPAC's redemption deadline, trust account value, extension provisions, or target-search status. The reported holding of 198,828 shares (0.7% of the class) reflects a standard broker-dealer position adjustment rather than a strategic accumulation or sponsor action. Because the filing contains no forward-looking statements, customer disclosures, revenue metrics, market analysis, technology updates, partnership announcements, litigation details, or personnel changes, it provides no new substantive information regarding deal progress, redemption mechanics, or sponsor conduct. The mechanical framework remains unchanged, and secondary market participants should treat this as a routine regulatory update rather than a catalyst for redemption or trust valuation shifts.

What changed: Definitive proxy statement for an extraordinary general meeting to approve an amendment to extend the deadline to complete a business combination. The filing proposes to extend the deadline from December 4, 2024 to January 4, 2025, and then allow up to 23 additional one-month extensions until December 4, 2026 without further shareholder vote, at the sponsor's request. It also includes an adjournment proposal. The trust value is approximately $11.45 per share with total $16,091,056.05. The company was delisted from NYSE American and now trades on OTC Pink. The sponsor and initial shareholders own 94.8% of shares and will vote in favor. The redemption deadline is November 22, 2024. Why it matters: This extension is critical for the SPAC to avoid liquidation and continue searching for a target. The high sponsor ownership ensures approval. Shareholders have redemption rights at ~$11.45 per share, which is above the recent market price of $11.30, creating an arbitrage opportunity. The delisting to OTC Pink reduces liquidity and could impact trading. The trust is now in cash earning minimal interest, so no further growth in trust value. The filing provides the specific mechanics for redemption and the timeline for the meeting on November 26, 2024.

What changed: Preliminary proxy statement (PRE 14A) filed by Jaws Mustang Acquisition Corp (JWSMF) for an extraordinary general meeting to vote on an amendment to extend the deadline to complete a business combination. The filing proposes to extend the termination date from December 4, 2024 to January 4, 2025, and then allow up to 23 additional monthly extensions (without further shareholder vote) until December 4, 2026. It also discloses that NYSE American has delisted the securities effective November 1, 2024, and the company will move to OTC trading. The trust account has been liquidated into cash (interest-bearing deposit account at ~3.5-4.5% per annum). The sponsor and initial shareholders own 95.2% of shares and will vote for the proposal. Redemption rights are offered to public shareholders. Why it matters: This is a critical extension vote. Without approval, the SPAC will liquidate by December 4, 2024. The trust balance is approximately $15.4 million after prior redemptions, and the public float is small. The delisting from NYSE American reduces liquidity and marketability. The extension would give the sponsor up to two more years to find a deal, but the company faces significant risks including potential further redemptions and the challenge of completing a business combination with a depleted trust. The outcome is highly likely to pass due to insider control, but the trust per-share value is well above the current trading price, creating an arbitrage opportunity for redeeming shareholders.

What changed: Form 8-K Current Report disclosing entry into a material definitive agreement (promissory note), NYSE American delisting proceedings, and suspension of a previously announced hospitality business combination. According to the November 1, 2024 press release attached as Exhibit 99.1, the company suspended pursuit of its March 8, 2024 non-binding letter of intent with Starwood Capital Group entities after Host Hotels & Resorts, Inc. acquired the 1 Hotel Central Park on July 31, 2024. NYSE American staff determined to suspend trading following a November 1, 2024 panel decision upholding delisting proceedings commenced under Sections 119(b) and 119(f) of the NYSE American Company Guide because the company failed to consummate a business combination within 36 months; the company intends to quote on OTC Markets but shareholders will not be required to exchange securities. Chief Executive Officer Andrew Klaber issued an interest-free promissory note on October 31, 2024, with a principal amount of up to $400,000 to Starwood Capital Group Management, L.L.C., maturing upon an initial business combination and stipulating that repayment will occur solely from funds remaining outside the trust account, if any, or the balance will be forgiven upon dissolution. Redeemable warrants maintain an exercise price of $11.50. Why it matters: The suspension of the hospitality target eliminates the active merger pathway, leaving the company in a pure search phase while preserving the existing trust account and shareholder equity structure. The $400,000 note establishes a direct financial obligation that explicitly waives claims against the trust account, meaning the payee recovers only from external corporate assets if a combination fails. The migration to OTC Markets maintains periodic reporting compliance under the Exchange Act without triggering mandatory redemptions or warrant conversions. As outlined in the company overview, Chairman Barry S. Sternlicht and Chief Executive Officer Andrew Klaber continue to oversee operations while seeking replacement hotel interests outside the Initial Portfolio.